US EditionPublished • loading... • Updated
Amplifi Vascular Gains FDA Breakthrough Device Status & CMS Category B
Summary by THE TIMES OF BENGAL
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Amplifi Vascular Gains FDA Breakthrough Device Status & CMS Category B
A Breakthrough in Dialysis Access ST. LOUIS, Jan. 13, 2026 /PRNewswire/ — Amplifi Vascular, Inc., has been granted Breakthrough Device Designation and Category B assignment from the Centers for Medicare & Medicaid Services (CMS) for the Amplifi Vein Dilation System. This significant recognition highlights the company’s innovative advancements in medical technology, marking a pivotal step in its mission to address critical healthcare needs. “This…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
